-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
iTeos Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- iTeos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.54M, a 6.89% increase year-over-year.
- iTeos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $30.1M, a 16.9% increase year-over-year.
- iTeos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $27M, a 25.3% increase from 2022.
- iTeos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $21.6M, a 56.3% increase from 2021.
- iTeos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.8M, a 221% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)